NanoDx

NanoDx

Signal active

Organization

Contact Information

Overview

NanoDx is a medical device start-up company commercializing easy-to-use, low-cost, handheld point-of-care products for the screening and monitoring of mild brain injury. It is redefining the identification and management of concussions which represent reported brain injuries.

About

Industries

Biotechnology, Health Care, Medical Device

Founded

2010

Employees

11-50

Headquarters locations

United States, North America

Social

N/A

Profile Resume

NanoDx headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical Device sector. The company focuses on Biotechnology and has secured $3.2B in funding across 84 round(s). With a team of 11-50 employees, NanoDx is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - NanoDx, raised $4.0M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Brian McGlynn

Brian McGlynn

Founder, Executive Vice President, Chief Technical Officer

imagePlace Sergey Dryga

Sergey Dryga

CSO, VP of Pilot Manufacturing

imagePlace George Serafin

George Serafin

Interim CEO

imagePlace Mike Sampson

Mike Sampson

Chief Commercial Officer

Funding Rounds

Funding rounds

7

Investors

0

Lead Investors

0

Total Funding Amount

$37.9M

Details

3

NanoDx has raised a total of $37.9M in funding over 3 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2020Late Stage Venture18.0M
2016Early Stage Venture4.0M
2013Early Stage Venture4.0M

Investors

NanoDx is funded by 9 investors.

Investor NameLead InvestorFunding RoundPartners
NanoDx-FUNDING ROUND - NanoDx2.0M
MedScience Ventures-FUNDING ROUND - MedScience Ventures2.0M
NanoDx-FUNDING ROUND - NanoDx4.0M
Provident Healthcare Capital-FUNDING ROUND - Provident Healthcare Capital4.0M

Recent Activity

There is no recent news or activity for this profile.